"Evaluating The Applicability of LASMAR Scoring in Predicting Surgical Outcomes Of Hysteroscopic Myomectomy"

N/ANot Yet RecruitingNCT07578246

Ain Shams University88 enrolled

Overview

This study aims to evaluate the applicability of the LASMAR scoring system, derived from hysteroscopy, in predicting surgical outcomes in patients undergoing hysteroscopic myomectomy for submucous fibroids.

This study aims to evaluate the applicability of LASMAR scoring in predicting surgical outcomes for cases of hysteroscopic myomectomy. By applying the LASMAR scoring system to patient , the study seeks to determine if the scoring can accurately predict operative time, completeness of resection, and complication rates.

Study Type

OBSERVATIONAL

Enrollment

Conditions

LAZMAR Scoring , Hysteroscopic Myomectomy

Interventions

Hysteroscopic MyomectomyPROCEDURE

Hysteroscopic myomectomy is a minimally invasive surgical procedure used to remove fibroids that are located inside the uterine cavity (submucosal fibroids).

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 45 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Women aged 18-45 years * Type 0,1,2 Fibroids according to Figo classification. * Symptomatic submucous fibroids: Symptoms include abnormal uterine bleeding, pelvic pain or pressure symptoms, infertility or recurrent pregnancy loss. * Fibroids size ≤ 5 cm in diameter * Confirmed diagnosis of leiomyoma by ultrasound . * Hemodynamically Stable Patients: Patients with no significant anemia. Exclusion Criteria: * Contraindications to hysteroscopy (e.g., Pregnancy, pyometra, active infection) * Individuals with significant comorbidities (e.g., severe cardiovascular or respiratory diseases, bleeding diathesis). * Cases requiring concurrent procedures (e.g., Laparoscopic surgeries). * Fibroid Size\>5 cm.

Outcomes

Primary Outcomes

Correlation between preoperative parameters assessed using the Lasmar score and operative parameters, including operative time, number of sessions needed for complete resection, fluid deficit and intraoperative complications.

Time frame: 2 years

Secondary Outcomes

Postoperative Complications: Including infection, adhesions, volume overload.

Time frame: 2 years

Need for Further Interventions: Incidence of additional treatments like hormonal therapy

Time frame: 2 years

Central Contacts

Yomna Ayman Salah, Master degree

CONTACT

01060666006 yomnasalah@med.asu.edu.eg

Ahmed Mohammed Selim, MD

CONTACT

011 15330063

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.